Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Schizophrenia

  Free Subscription


Articles published in Can J Psychiatry

Retrieve available abstracts of 36 articles:
HTML format



Single Articles


    September 2026
  1. LIU JCW, Gorbovskaya I, Zhang AY, Hahn MK, et al
    Investigation of the Gut Microbiome in Treatment-Resistant Schizophrenia Compared to Healthy Controls: A Cross-Sectional Pilot Study: Etude du microbiome intestinal chez les patients atteints de schizophrenie resistante au traitement par rapport aux t
    Can J Psychiatry. 2026 Sep 18:7067437261487782. doi: 10.1177/07067437261487782.
    PubMed     Abstract available


  2. YANG L, Ross K, Palmer M, Ye Q, et al
    Adherence and Acceptability of Smartphone- and Wearable-Based Digital Phenotyping in Patients With First-Episode Psychosis: Observance et acceptabilite du phenotypage numerique fonde sur les telephones intelligents et les objets personnels connectes c
    Can J Psychiatry. 2026 Sep 11:7067437261486958. doi: 10.1177/07067437261486958.
    PubMed     Abstract available


  3. MIRABELLI J, MacKillop J, Streiner D, Korostil M, et al
    Cannabis Use Interacts With Psychosis Vulnerability in Borderline Personality Disorder: La consommation de cannabis interagit avec la vulnerabilite a la psychose dans le trouble de la personnalite limite.
    Can J Psychiatry. 2026 Sep 11:7067437261486962. doi: 10.1177/07067437261486962.
    PubMed     Abstract available


  4. SKIBA RM, Woodward TS, Caramanna I, Honer WG, et al
    A Multivariate Approach to Communication Impoverishment and Cognitive Performance in Treatment-Resistant Schizophrenia: Analyse a plusieurs variables portant sur l'appauvrissement de la communication et la performance cognitive dans les cas de schizop
    Can J Psychiatry. 2026 Sep 7:7067437261484787. doi: 10.1177/07067437261484787.
    PubMed     Abstract available


    June 2026
  5. STIP E, Courteau J, Brodeur S, Chiu YM, et al
    Healthcare Pattern of Use Before and After Initiating a Long-Acting Antipsychotic Among a Cohort of 6221 Patients With a History of Psychosis.
    Can J Psychiatry. 2026 Jun 29:7067437261462697. doi: 10.1177/07067437261462697.
    PubMed     Abstract available


  6. STAPLES JA, Daly-Grafstein D, Khan M, Erdelyi S, et al
    Acute Psychosis and the Risk of Motor Vehicle Crash: Psychose aigue et risque d'accident de la route.
    Can J Psychiatry. 2026 Jun 2:7067437261454782. doi: 10.1177/07067437261454782.
    PubMed     Abstract available


    May 2026
  7. UELAND T, Oie MG, Vaskinn A
    Methodological Concerns Regarding a Meta-Analysis of the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS).
    Can J Psychiatry. 2026 May 7:7067437261448737. doi: 10.1177/07067437261448737.
    PubMed    


    April 2026
  8. LU Y, Todesco B, Hawke LD, Kozloff N, et al
    Optimizing Health for Canadian Youth at Clinical High Risk for Psychosis: A Feasibility Study: Optimiser la sante des jeunes Canadiens presentant un risque clinique eleve de psychose : Une etude de faisabilite.
    Can J Psychiatry. 2026 Apr 7:7067437261436536. doi: 10.1177/07067437261436536.
    PubMed     Abstract available


    March 2026
  9. WHITE N, Potvin S, Do A, Stip E, et al
    Cognitive Complaints in Schizophrenia: A Meta-Analysis of Studies Using the Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS): Les plaintes cognitives dans la schizophrenie : Une meta-analyse des etudes utilisant la Subjective Scale
    Can J Psychiatry. 2026 Mar 3:7067437261425086. doi: 10.1177/07067437261425086.
    PubMed     Abstract available


  10. FRANKOW L, Bousman CA, Mathew N, Rafizadeh R, et al
    Clozapine Therapy With or Without Antipsychotic Augmentation: A Retrospective Evaluation of Prescribing Practices in a Canadian Provincial Residential Treatment Centre for Concurrent Disorders: Traitement par la clozapine avec ou sans intensification
    Can J Psychiatry. 2026;71:210-218.
    PubMed     Abstract available


    February 2026
  11. BARKER LC, Zaheer J, Wong-Lee R, Kearney H, et al
    Building a Sexual and Reproductive Health Module for Implementation in Early Psychosis Programs: A Co-creation Process: Creation d'un module sur la sante sexuelle et reproductive a mettre en oeuvre dans les programmes d'intervention precoce en cas de
    Can J Psychiatry. 2026 Feb 18:7067437261420713. doi: 10.1177/07067437261420713.
    PubMed     Abstract available


    December 2025
  12. MARTIN H, Valle R, Pawliuk N, Iyer SN, et al
    Family-Focused Recommendations in Canadian Guidelines for Early Intervention Services for Psychosis: A Systematic Review: Recommandations axees sur la famille dans les Lignes directrices canadiennes relatives aux services d'intervention precoce en cas
    Can J Psychiatry. 2025 Dec 10:7067437251393981. doi: 10.1177/07067437251393981.
    PubMed     Abstract available


    October 2025
  13. SKIBA RM, Chinchani AM, Menon M, Lepage M, et al
    A multisite study of the overlap between symptoms and cognition in schizophrenia: Une etude multicentrique sur le chevauchement entre les symptomes et les troubles cognitifs chez les personnes atteintes de schizophrenie.
    Can J Psychiatry. 2025 Oct 22:7067437251387565. doi: 10.1177/07067437251387565.
    PubMed     Abstract available


    September 2025
  14. LIU S, Tang S, Tan Y, Xiang B, et al
    Influence of Virtual Reality on Negative Symptoms and Quality of Life of Patients With Schizophrenia: A Meta-Analysis: Influence de la realite virtuelle sur les symptomes negatifs et la qualite de vie des patients atteints de schizophrenie : une meta-
    Can J Psychiatry. 2025 Sep 2:7067437251372186. doi: 10.1177/07067437251372186.
    PubMed     Abstract available


    July 2025
  15. COPPOLA AM, McDonald J, Jimenez AM, Cao J, et al
    Non-Linear Relationships of Loneliness with Age in People Living with Schizophrenia and Non-Psychiatric Comparison Participants: Relations non lineaires entre la solitude et l'age chez les personnes atteintes de schizophrenie et les personnes n'ayant
    Can J Psychiatry. 2025 Jul 28:7067437251355636. doi: 10.1177/07067437251355636.
    PubMed     Abstract available


  16. COLIJN MA
    Rare Genetic Variation and Psychosis: Treatment Considerations for Psychiatrists.
    Can J Psychiatry. 2025 Jul 21:7067437251339793. doi: 10.1177/07067437251339793.
    PubMed    


  17. WIENER JC, Rodrigues R, Reid JNS, Archie S, et al
    Early Psychosis Symptoms Noted by Family Physicians in Electronic Medical Records During Help-Seeking Visits in Primary Care: Symptomes precoces de psychose releves par les medecins generalistes dans les dossiers medicaux electroniques lors de consult
    Can J Psychiatry. 2025 Jul 7:7067437251355637. doi: 10.1177/07067437251355637.
    PubMed     Abstract available


    May 2025
  18. LEVIN Y, Mazza A, Hyland P, Karatzias T, et al
    Positive Symptoms of Psychosis and International Classification of Diseases 11th Revision (ICD-11) Complex Post-traumatic Stress Disorder: A Network Analysis in a Canadian Sample from Montreal: Symptomes positifs de psychose et trouble de stress post-
    Can J Psychiatry. 2025 May 15:7067437251337645. doi: 10.1177/07067437251337645.
    PubMed     Abstract available


    April 2025
  19. ROTENBERG M, Graffi J, Anderson K, Kurdyak P, et al
    A Geospatial Analysis of Early Psychosis Intervention Programs in Toronto, Canada: Une analyse geospatiale des programmes d'intervention precoce en cas de psychose a Toronto, au Canada.
    Can J Psychiatry. 2025 Apr 29:7067437251337807. doi: 10.1177/07067437251337807.
    PubMed     Abstract available


  20. LU Y, Hedemann TL, Hawke LD, Ampofo A, et al
    Adaptation of a Psychosocial Intervention for Canadian Youth at Clinical High Risk for Psychosis: Adaptation d'une intervention psychosociale pour les jeunes a haut risque clinique de psychose au Canada.
    Can J Psychiatry. 2025 Apr 13:7067437251328357. doi: 10.1177/07067437251328357.
    PubMed     Abstract available


  21. METIVIER L, Trehout M, Leroux E, Rotharmel M, et al
    French Validation of the Brief Negative Symptom Scale (BNSS).
    Can J Psychiatry. 2025;70:312-319.
    PubMed     Abstract available


    March 2025
  22. RAE J, Lavigne KM, Sauve G, Lepage M, et al
    Mapping Insight Dimensions and Symptom Dynamics in Schizophrenia: A Data-Driven Network Approach: Cartographie des dimensions d'insight et de la dynamique symptomatique dans la schizophrenie: une approche par reseau fondee sur les donnees.
    Can J Psychiatry. 2025 Mar 21:7067437251329074. doi: 10.1177/07067437251329074.
    PubMed     Abstract available


  23. ZIPURSKY RB, Agid O, Kiang M, Remington G, et al
    Clinical Correlates of Antipsychotic Plasma Levels with Long-Acting Paliperidone: Correlats cliniques des concentrations plasmiques de paliperidone a liberation prolongee.
    Can J Psychiatry. 2025;70:209-216.
    PubMed     Abstract available


    December 2024
  24. ZIPURSKY RB
    Rethinking Schizophrenia-A Manageable Chronic Condition.
    Can J Psychiatry. 2024 Dec 10:7067437241301572. doi: 10.1177/07067437241301572.
    PubMed    


  25. VAN L, Heung T, Reyes NGD, Boot E, et al
    Real-World Treatment of Schizophrenia in Adults With a 22q11.2 Microdeletion: Traitement dans le monde reel de la schizophrenie chez des adultes atteints du syndrome de microdeletion 22q11.2.
    Can J Psychiatry. 2024 Dec 6:7067437241293983. doi: 10.1177/07067437241293983.
    PubMed     Abstract available


  26. WEIDENAUER A, Garani R, Campos Oller P, Belen Blasco M, et al
    Impact of Stress on the Endocannabinoid System: A [(11)C]-CURB Positron Emission Tomography Study in Early Psychosis: Les effets du stress sur le systeme endocannabinoide : etude par tomographie par emission de positons avec l'indicateur radioactif [1
    Can J Psychiatry. 2024 Dec 4:7067437241300958. doi: 10.1177/07067437241300958.
    PubMed     Abstract available


    November 2024
  27. DEVOE DJ, Liu L, Braun A, Cadenhead KS, et al
    Cognitive-Behavioural Social Skills Training: Mediation of Treatment Outcomes in a Randomized Controlled Trial for Youth at Risk of Psychosis: L'entrainement aux competences sociales cognitivo-comportementales : variables mediatrices des resultats the
    Can J Psychiatry. 2024 Nov 11:7067437241295636. doi: 10.1177/07067437241295636.
    PubMed     Abstract available


  28. KASTER TS, Babujee A, Sharpe I, Rhee TG, et al
    Clinical Characteristics of Inpatients with Schizophrenia Spectrum Disorder Treated with Electroconvulsive Therapy: A Population-Level Cross-Sectional Study: Titre: Caracteristiques cliniques des patients hospitalises presentant un trouble du spectre
    Can J Psychiatry. 2024 Nov 11:7067437241290181. doi: 10.1177/07067437241290181.
    PubMed     Abstract available


  29. FAN L, Zhang Z, Ma X, Liang L, et al
    Brain Age Gap as a Predictor of Early Treatment Response and Functional Outcomes in First-Episode Schizophrenia: A Longitudinal Study: L'ecart d'age cerebral comme predicteur de la reponse en debut de traitement et des resultats fonctionnels dans un p
    Can J Psychiatry. 2024 Nov 10:7067437241293981. doi: 10.1177/07067437241293981.
    PubMed     Abstract available


  30. ALARABI M, Burton L, Powell V, Isinger T, et al
    Formal Thought Disorders and Neurocognition in Treatment-Resistant Schizophrenia: Trouble du cours de la pensee et neurocognition dans la schizophrenie refractaire.
    Can J Psychiatry. 2024 Nov 4:7067437241293985. doi: 10.1177/07067437241293985.
    PubMed     Abstract available


  31. BARBER S, Mulushoa A, Hanlon C, Malla A, et al
    Psychosis and Gender: A Focus on Women in the Global South.
    Can J Psychiatry. 2024 Nov 3:7067437241295301. doi: 10.1177/07067437241295301.
    PubMed    


    October 2024
  32. KORANN V, Panganiban KJ, Stogios N, Remington G, et al
    The Dysregulation of the Glymphatic System in Patients with Psychosis Spectrum Disorders Minimally Exposed to Antipsychotics: La deregulation du systeme glymphatique en presence de troubles psychotiques chez des patients peu exposes a des antipsychoti
    Can J Psychiatry. 2024 Oct 21:7067437241290193. doi: 10.1177/07067437241290193.
    PubMed     Abstract available


    July 2024
  33. LEPAGE M, Guimond S, Raedler T, McNeely HE, et al
    Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Strategies pour atteindre une meilleure sante cognitive chez les personnes souffrant du spectre de la schizophrenie : un re
    Can J Psychiatry. 2024 Jul 25:7067437241261928. doi: 10.1177/07067437241261928.
    PubMed     Abstract available


    April 2024
  34. CORONADO-MONTOYA S, Abdel-Baki A, Crockford D, Cote J, et al
    Preferences of Young Adults With Psychosis for Cannabis-Focused Harm Reduction Interventions: A Cross-Sectional Study: Preferences des jeunes adultes souffrant de psychose pour les interventions de reduction des mefaits axees sur le cannabis : une etu
    Can J Psychiatry. 2024 Apr 4:7067437241242395. doi: 10.1177/07067437241242395.
    PubMed     Abstract available


    February 2024
  35. L'HEUREUX S, Huot-Lavoie M, Bergeron A, Bergeron C, et al
    Effect of Cannabis Legalization in Canada on the Incidence of Psychosis Consultations in Quebec City's Psychiatric Emergency Services.
    Can J Psychiatry. 2024 Feb 21:7067437241232901. doi: 10.1177/07067437241232901.
    PubMed    


    September 2023
  36. CHEN S, Lee A, Wang W
    A Meta-Research of Randomized Controlled Trials in the Field of Mental Health: Comparing Pharmacological to Non-Pharmacological Interventions from 1955 to 2020.
    Can J Psychiatry. 2023;68:639-648.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum